Usage of cookies

We would like to use cookies to better understand your use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our Privacy policy.

Skip to content

Press Release

Cian Healy launches drug-free gel for joint pain and stiffness.

Leinster and Ireland rugby star Cian Healy today launches FLEXISEQ Sport, a drug-free gel designed to protect the joints in all active people.

The product has been developed alongside professional athletes across a range of sporting disciplines to manage joint pain and restore function, without the use of drugs.

It lubricates the joints and allows users to stay fit without the distraction of pain and stiffness and overuse of painkillers.

Each batch of FLEXISEQ Sport is screened to be free of any trace substances banned by the World Anti-Doping Agency (WADA), so it can be used by elite athletes, and others subject to anti-doping screenings.

Leinster, Ireland and Lions prop Cian uses the gel as part of his preparation and recovery programmes.

Six Nations star Cian said: “FLEXISEQ Sport has been a great addition to managing my recovery from injury.

“Like all players, I’m always looking to get the edge. We’re always chasing that extra one per cent, and effective recovery is a huge part of that. The gel is now part of my overall routine, as using it helps protect my joints and deal with any niggles.”

John Mayo, CEO of the gel’s manufacturers Pro Bono Bio, said: “FLEXISEQ Sport offers everyone the safe option in pain relief and direct joint maintenance to avoid further problems.

“Whether you’re a professional or amateur sportsperson or someone who simply enjoys an active lifestyle, you need to stay mobile for a fit, productive and happy life.” FLEXISEQ Sport is available at pharmacies nationwide — a 50g tube is priced at €23.45.

For more information visit

About Ascension Healthcare plc

Ascension Healthcare plc is a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for the treatment of haemophilia and osteoarthritis. The Company has three products in clinical development for the treatment of haemophilia A and also a range of internationally marketed products for osteoarthritis sufferers. For more information please visit:

For more information contact

Ascension Healthcare plc
Biresh Roy, Chief Executive Officer

[email protected] / +44 (0)20 7291 5400

Consilium Strategic Communications
(European Media and Investor Enquiries)
Lindsey Neville, Ashley Tapp

Tel: +44 (0)20 3709 5700 / [email protected]